Literature DB >> 8681787

Oligodendrocyte progenitors are generated throughout the embryonic mouse brain, but differentiate in restricted foci.

R J Hardy1, V L Friedrich.   

Abstract

Recent evidence from studies mapping the expression of putative oligodendrocyte progenitor specific mRNAs has suggested that oligodendrocyte progenitors arise during embryogenesis, in specific foci of the neuroectoderm. In order to test this hypothesis, we have assayed different regions of the embryonic central nervous system for their ability to generate oligodendrocytes following transplantation into neonatal cerebrum. To allow identification of donor-derived oligodendrocytes in wild-type host brain, we used the MbetaP transgenic mouse, which expresses lacZ in oligodendrocytes, as donor tissue. We found that tissue fragments derived from several levels of the anterior-posterior axis of the neural tube at E14.5 and E12.5, chosen to include (hindbrain, cervical and lumbar spinal cord), or exclude (dorsal telencephalon) putative foci of oligodendrocyte progenitors, all produced oligodendrocytes following transplantation. In addition, these same regions taken from E10.5, prior to the appearance of putative oligodendrocyte progenitor markers, also all yielded oligodendrocytes on transplantation. This indicates that precursor cells that can generate oligodendrocytes are widespread throughout the neuroectoderm as early as E10.5. We have also used the oligodendrocyte lineage-specific glycolipid antibodies O4, R-mAb and O1 to identify those regions of the developing brain that first support the differentiation of oligodendrocytes from their progenitor cells. We found that the first oligodendrocytes arise in prenatal brain at E14.5, in a restricted zone adjacent to the midline of the medulla. These cells are mitotically inactive, differentiated oligodendrocytes and, using light and electron microscopy, we show that they become functional, myelin-bearing oligodendrocytes. We have mapped the subsequent appearance of differentiated oligodendrocytes in the prenatal brain and show that they appear in a restricted, tract-specific manner. Our results suggest that oligodendrocytes are generated from neuroectodermal cells positioned throughout the rostrocaudal axis of the neural tube, rather than at restricted locations of the neuroectoderm. By contrast, the differentiation of such cells into oligodendrocytes does occur in a restricted manner, consistent with local regulation of oligodendrocyte progenitor differentiation.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8681787     DOI: 10.1242/dev.122.7.2059

Source DB:  PubMed          Journal:  Development        ISSN: 0950-1991            Impact factor:   6.868


  25 in total

1.  Cell-surface glycoprotein of oligodendrocyte progenitors involved in migration.

Authors:  A Niehaus; J Stegmüller; M Diers-Fenger; J Trotter
Journal:  J Neurosci       Date:  1999-06-15       Impact factor: 6.167

2.  Multiple roles of bone morphogenetic protein signaling in the regulation of cortical cell number and phenotype.

Authors:  P C Mabie; M F Mehler; J A Kessler
Journal:  J Neurosci       Date:  1999-08-15       Impact factor: 6.167

3.  Developing neocortex organization and connectivity in cats revealed by direct correlation of diffusion tractography and histology.

Authors:  Emi Takahashi; Guangping Dai; Glenn D Rosen; Ruopeng Wang; Kenichi Ohki; Rebecca D Folkerth; Albert M Galaburda; Van J Wedeen; P Ellen Grant
Journal:  Cereb Cortex       Date:  2010-05-21       Impact factor: 5.357

4.  Mouse intermittent hypoxia mimicking apnoea of prematurity: effects on myelinogenesis and axonal maturation.

Authors:  Jun Cai; Chi Minh Tuong; Yiping Zhang; Christopher B Shields; Gang Guo; Hui Fu; David Gozal
Journal:  J Pathol       Date:  2011-10-18       Impact factor: 7.996

5.  Focal adhesion kinase can play unique and opposing roles in regulating the morphology of differentiating oligodendrocytes.

Authors:  Audrey D Lafrenaye; Babette Fuss
Journal:  J Neurochem       Date:  2010-08-19       Impact factor: 5.372

6.  A high-resolution spatiotemporal atlas of gene expression of the developing mouse brain.

Authors:  Carol L Thompson; Lydia Ng; Vilas Menon; Salvador Martinez; Chang-Kyu Lee; Katie Glattfelder; Susan M Sunkin; Alex Henry; Christopher Lau; Chinh Dang; Raquel Garcia-Lopez; Almudena Martinez-Ferre; Ana Pombero; John L R Rubenstein; Wayne B Wakeman; John Hohmann; Nick Dee; Andrew J Sodt; Rob Young; Kimberly Smith; Thuc-Nghi Nguyen; Jolene Kidney; Leonard Kuan; Andreas Jeromin; Ajamete Kaykas; Jeremy Miller; Damon Page; Geri Orta; Amy Bernard; Zackery Riley; Simon Smith; Paul Wohnoutka; Michael J Hawrylycz; Luis Puelles; Allan R Jones
Journal:  Neuron       Date:  2014-06-19       Impact factor: 17.173

7.  B-1a lymphocytes promote oligodendrogenesis during brain development.

Authors:  Shogo Tanabe; Toshihide Yamashita
Journal:  Nat Neurosci       Date:  2018-03-05       Impact factor: 24.884

8.  Surface based analysis of diffusion orientation for identifying architectonic domains in the in vivo human cortex.

Authors:  Jennifer A McNab; Jonathan R Polimeni; Ruopeng Wang; Jean C Augustinack; Kyoko Fujimoto; Allison Stevens; Christina Triantafyllou; Thomas Janssens; Reza Farivar; Rebecca D Folkerth; Wim Vanduffel; Lawrence L Wald
Journal:  Neuroimage       Date:  2012-12-16       Impact factor: 6.556

9.  Miswiring the brain: Δ9-tetrahydrocannabinol disrupts cortical development by inducing an SCG10/stathmin-2 degradation pathway.

Authors:  Giuseppe Tortoriello; Claudia V Morris; Alan Alpar; Janos Fuzik; Sally L Shirran; Daniela Calvigioni; Erik Keimpema; Catherine H Botting; Kirstin Reinecke; Thomas Herdegen; Michael Courtney; Yasmin L Hurd; Tibor Harkany
Journal:  EMBO J       Date:  2014-01-27       Impact factor: 11.598

10.  Regulation of oligodendrocyte progenitor cell maturation by PPARδ: effects on bone morphogenetic proteins.

Authors:  Maria Vittoria Simonini; Paul E Polak; Anne I Boullerne; Jeffrey M Peters; Jill C Richardson; Douglas L Feinstein
Journal:  ASN Neuro       Date:  2010-01-15       Impact factor: 5.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.